Thursday, December 8, 2016



emka TECHNOLOGIES S.A.S. (Paris, France)
Closed from Monday, December 26th to Friday, December 30th.

emka TECHNOLOGIES Inc. (Falls Church, VA, U.S.A.)
Closed on Monday, December 26th to Monday, January 2nd only. Open all other days.

SCIREQ Scientific Respiratory Equipment Inc. (Montreal, QC, Canada)
Closed from Monday, December 26th to Monday, January 2nd.

Wednesday, November 30, 2016

Lung Function in Conscious Subjects

Conscious measurements allow researchers to quantify effects of diseases or therapeutic interventions on the drive to breathe, also referred to as “Pumping apparatus” 1. The breathing drive involves different components that regulate respiration including respiratory muscles, the central nervous system, and chemo/mechano-receptors. Outcomes such as tidal volume, respiratory rate, minute volume, inspiratory, expiratory, and apneic periods are particularly useful in safety pharmacology studies, and research into sleep and neuromuscular diseases. Whole body plethysmography (WBP) is the simplest and least invasive approach that permits conscious in vivo measurements. However, researchers must consider the inherent limitations of WBP2 in regards to the accuracy of breathing volumes and assessment of airway hyperresponsiveness. Other techniques such as head-out plethysmography (HOP) or double chamber plethysmography (DCP) are often useful in providing a more accurate and validated assessment of the lung function.  

EF50 – a valid indicator of airway response

In difference to WBP, where the subject is freely moving within a chamber, HOP/DCP measurements are acquired in restrained subjects, allowing true inspiratory and expiratory flow measurements and their corresponding parameters. One such outcome, the tidal mid-expiratory flow (EF50), is particularly interesting as it has been described and validated over the last 20 years as an index of flow limitation and airway obstruction.  The parameter is calculated on a breath-by-breath basis during spontaneous tidal breathing and typically decreases in presence of airflow obstruction.

Other Applications

EF50 is often used in respiratory safety pharmacology studies performed under the ICH 7AS guidelines, where the HOP technique is a standard for conscious lung function assessment.  However, the parameter can also be obtained with DCP, allowing for exposure to nebulized substances and/or the ability to record nasal and thoracic flows separately.  Using this approach, EF50 can also be used to describe airway responsiveness changes to broncho-active substances in conscious mice, either na├»ve or allergic. 

Since EF50 does not provide a direct measurements of resistance, it is generally accepted that any change in this parameter would be followed by a comprehensive lung function assessment such as that provided by the flexiVent system.


  • 1Murphy DJ, 2013. Respiratory safety pharmacology – Current practice and future direction. Regulatory Toxicology and Pharmacology 69. DOI: 10.1016/j.yrtph.2013.11.010
  • 2Bates et al., 2003. Measuring lung function in mice: the phenotyping uncertainty principle.  J. of Appl. Physiology 1297-306. DOI: 10.1152/japplphysiol.00706.2002
  • Hoymann HG, 2012. Lung function measurements in rodents in safety pharmacology. Frontiers in pharmacology 3: article 156. doi: 10.3389/fphar.2012.00156.
  • Glaab T et al., 2001. Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol Physiol 280: L565-573.
  • Vijayaraghavan R et al., 1993. Characteristic modifications of the breathing pattern in mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch Toxicol 67: 478-490.
  • Walker JKL et al., 2013. Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics. Frontiers in pharmacology 3: article 491. doi: 10.3389/fphar.2012.00491.

Wednesday, November 9, 2016


The emka & SCIREQ team will be attending the Society for Neuroscience 2016 conference in San Diego! We will present and demonstrate our wide range of preclinical instruments for neuro, pulmonary and cardio studies. Come by booth #3533 and speak with our experienced team about our solutions for physiology, pharmacology and toxicology research.

 A special focus on optogenetics

Optogenetic studies targeting respiratory centers in the brain stem can be paired with whole body plethysmography (WBP) to measure pulmonary function.

» Our WBP chambers pair with fibre optic cables to offer real-time assessment of lung function changes resulting from optical manipulation.
» Does not require anaesthetics, which can depress the neural-network controlling respiration.
» Conscious, freely moving subjects that have the ability to respond to real-time optical challenges.
» Swivel/tether system for measurement of other physiological parameters (ECG, EEG) or blood sampling following injections.
» Easily integrated with gas challenges (CO2/O2) to further induce or inhibit signaling pathways.
» Measures ventilatory parameters: Respiratory Rate (RR), estimated Tidal Volume (VT), Minute Ventilation (V) or Periodic breathing


easyTEL implantable system transmits physiological data from conscious freely moving laboratory animals. Our range of implants offers the ability to record the following parameters, depending on your study needs:

» Biopotential (ECG, EEG, EMG)
» Blood pressure
» Temperature
» Activity from acceleration

Click here to schedule a meeting with one of our specialists during SFN 2016.

Friday, November 4, 2016


Thank you to Drs. Teodorescu and Broytman at the University of Wisconsin-Madison for hosting an introductory workshop and seminar on Lung Function Measurements in Rodents. Research and Development Manager, Liah Fereydoonzad, and Application Specialist, John Morse, worked with participants at the workshop to perform an automated dose-response study in an allergic model with the flexiVent.

The seminar presentation discussed a variety of solutions for in vivo lung physiology, from non-invasive whole body plethysmography to detailed respiratory mechanics with the flexiVent. An application specific approach to the outcomes of each method was presented, as the detail of outcomes is determined by the invasiveness of the technique1.

Please contact us to find out more about lung function measurements or if you are interested in hosting a similar event!

1 J. H. Bates and C. G. Irvin, "Measuring lung function in mice: the phenotyping uncertainty principle.," Journal of Applied Physiology, vol. 94, p. 1297, 2003.

Monday, October 24, 2016

Thank you for meeting us at the 2016 Pittsburgh-Munich Lung Conference!

As it was our first time in attendance at the annual Pittsburgh-Munich Lung Conference, we would like to extend our thanks to the Division of Pulmonary and Critical Care Medicine at the University of Pittsburgh for such a warm welcome. The meeting was an excellent occasion to speak with current customers and other prominent researchers helping to improve our understanding of pulmonary immune response, inflammatory pathways and innovative approaches to treating respiratory disease.

Contact us to learn more about our suite of technology for respiratory research.

Phone 1.514.286.1429 | Toll Free 1.877.572.4737 | Email

Monday, October 3, 2016

At the Forefront of Preclinical Tobacco Research

Smoking has reached an epidemic proportion worldwide and its effect in terms of health-related issues is huge. While smoking prevention and cessation are key to bringing an end to this epidemic, scientific research is needed both to understand smoke-induced pathophysiological mechanisms and to develop novel therapeutic agents to treat patients. The smoking market is also changing, as seen with the introduction of new nicotine delivery devices, such as electronic cigarettes. Their rapid adoption has raised a lot of questions relating to the safety and benefits of these devices, most of which remain incompletely addressed at the present day.

Given the extended time period needed to generate sound scientific evidence, research on tobacco or tobacco-related products requires a joint effort. SCIREQ is proud to be part of these efforts by offering state-of-the-art equipment for basic in vivo and in vitro studies. Particularly well adapted to generate consistent and reproducible exposure environments is the inExpose system, a versatile and programmable exposure system that can be configured with several smoke and vape generating devices. The impact on the respiratory system can then be assessed using invasive and non-invasive lung function measurement techniques. Sitting at the forefront, the flexiVent system offers a variety of lung function measurements to address specific questions or gain novel insights. These accurate and detailed measurements can be complemented by the non-invasive barometric monitoring of the ventilation profile or disease symptoms (e.g. cough) throughout a study, which can involve repeated exposure sessions over several months. Finally, any direct effect on either airway or vascular smooth muscle can also be evaluated in absence of external influences using tissue baths for an overall meaningful and far-reaching assessment.

Please contact us to find out more or visit our website at